| Patents for C07D 205 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom (6,868) |
|---|
| 06/26/2003 | US20030120088 Hydrogenation catalyst for asymmetrically reducing prochiral ketone or imine |
| 06/26/2003 | US20030119858 Conformationally constrained compounds as pharmaceutical agents |
| 06/26/2003 | US20030119810 Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and their preparation |
| 06/26/2003 | US20030119809 Methods and therapeutic combinations for the treatment of xanthoma using sterol absorption inhibitors |
| 06/26/2003 | US20030119757 Methods for treating or preventing vascular inflammation using sterol absorption inhibitor(s) |
| 06/25/2003 | EP1321454A1 Process for the removal of nitrobenzenesulfonyl |
| 06/19/2003 | WO2003050154A2 Catalytic carbonylation of three and four membered heterocycles |
| 06/19/2003 | US20030114490 New phenylalanine derivatives |
| 06/19/2003 | US20030114419 Taxane derivatives having a tricyclic or tetracyclic core; remarkable properties in vitro; valuable antileukemia, antitumor and anticarcinogenic agents; human cancer cell line comparable to that of taxol and taxotere |
| 06/18/2003 | EP1319660A1 Optically active azetidincarboxamide-coordinated transition metal complexes as catalysts in asymmetric reduction |
| 06/18/2003 | EP1318988A2 Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission) |
| 06/18/2003 | EP1318978A2 N-acylsulfonamide apoptosis promoters |
| 06/18/2003 | EP1318806A1 Fatty acid synthase inhibitors |
| 06/18/2003 | CN1425002A Pyrrolidine and piperidine derivatives and their use for treatment of neurodegenerative disorders |
| 06/18/2003 | CN1111520C Matrix metalloprotease inhibitors |
| 06/18/2003 | CN1111410C Process for preparation of pharmaceutical composition |
| 06/17/2003 | US6579890 Matrix metalloprotease inhibitors |
| 06/12/2003 | WO2003047568A1 N-aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity |
| 06/12/2003 | WO2002046199A8 Process and ester derivatives useful for preparation of cephalosporins |
| 06/12/2003 | US20030109719 Process for cyclizing optically active 4-amino-2-halogenobutyric acids |
| 06/12/2003 | US20030109527 Novel hydroxy diphenylurea sulfonamides, compositions and intermediates thereof. The hydroxy |
| 06/12/2003 | CA2468967A1 N-aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity |
| 06/11/2003 | CN1423633A Azetidine derivatives, preparation thereof and pharmaceutical compositions |
| 06/10/2003 | US6576657 Amidino derivatives and their use as thrombin inhibitors |
| 06/05/2003 | US20030105099 Novel compounds and compositions as cathepsin inhibitors |
| 06/05/2003 | US20030105072 Compounds, compositions, and methods for controlling biofilms |
| 06/04/2003 | EP1316610A1 Preparation comprising an enzyme for asymmetrical hydrolysis of N-substituted C3-C4 cyclic imino-2-carboxylic acid ester and method of using the same |
| 06/04/2003 | EP1315749A2 Protein extracted from the intestines of vertebrates, which absorbs cholesterol, and the use of this protein for identifying inhibitors of intestinal cholesterol transport |
| 06/04/2003 | EP0912755B1 The bioresolution of n-acylazetidine-2-carboxylic acids |
| 06/04/2003 | EP0759437B1 Processes for the production of 2-isocephem derivatives |
| 06/04/2003 | EP0638552B1 Process for synthesizing 4-substituted azetidinone derivative |
| 05/30/2003 | WO2003043985A1 Heterocyclic compounds and methods of use |
| 05/30/2003 | WO2003043980A1 Azetidinyl diamines useful as ligands of the nociceptin receptor orl-1 |
| 05/28/2003 | EP1222305A4 Enzymatic process for the resolution of enantiomeric mixtures of beta-lactams |
| 05/27/2003 | US6569847 Inhibitors of cathepsins for treating muscular dystrophy, osteoporosis, rheumatoid arthritis, neuronal or cardiac ischaemia, allergy, or Chagas disease |
| 05/22/2003 | WO2002026705A8 Highly enantiomerically pure lactam-substituted propanoic acid derivatives and their preparation |
| 05/22/2003 | US20030097004 3,4-Di-substituted cyclobutene-1,2-diones as CXC chemokine receptor antagonists |
| 05/21/2003 | EP1311480A1 New amidino derivatives and their use as thrombin inhibitors |
| 05/21/2003 | EP1311475A1 Novel aminocyclohexane derivatives |
| 05/21/2003 | EP0874818B1 Novel substituted aryl compounds useful as modulators of acetylcholine receptors |
| 05/21/2003 | CN1419534A Diphenyl ether compounds useful in therapie |
| 05/21/2003 | CN1418882A Substituted sulfonic N-[(amino imino methyl) phenyl alkyl]-acacycloamide compound |
| 05/20/2003 | US6566356 3-amido or 3-sulfonylamino azetidine compounds and their preparation; high affinity for cannabinoid receptor CB1 type, useful in treating central nervous system, immune, gastrointestinal or cardiovascular disorders, drug abuse |
| 05/15/2003 | WO2003040097A1 Nitrogenous compounds, production process, and method of use thereof |
| 05/15/2003 | US20030092746 Substituted amidine derivatives as inhibitors of cell adhesion |
| 05/14/2003 | EP0667772B1 Taxanes having an alkyl substituted side-chain and pharmaceutical compositions containing them |
| 05/14/2003 | CN1418192A Pharmaceutical compositions containing azetidine derivatives novel azetidine derivatives and preparation thereof |
| 05/13/2003 | US6562962 Preparation of substituted isoserine esters using metal alkoxides and β-lactams |
| 05/13/2003 | CA2115443C Azabicyclo arylacetylene and arylenyne oximes as cholinergic agents and methods of treatment |
| 05/08/2003 | WO2003037338A2 Modulators of the cholesterol biosynthetic pathway |
| 05/08/2003 | WO2003037271A2 Compounds, pharmaceutical compositions and methods of use therefor |
| 05/08/2003 | WO2002026750A8 Phosphino-aminophosphines, catalyst complexes and enantioselective hydrogenation |
| 05/08/2003 | US20030087945 Sulfonylaminocarboxylic acids |
| 05/07/2003 | EP1112251B1 Azetidine derivatives, preparation and medicines containing them |
| 05/06/2003 | US6559140 Cyclic and bicyclic diamino histamine-3 receptor antagonists |
| 05/01/2003 | WO2003035055A1 Mch antagonists for the treatment of obesity |
| 05/01/2003 | WO2002058685A3 Combinations of nicotinic acid and derivatives thereof and sterol absorption inhibitor(s) and treatments for vascular indications |
| 05/01/2003 | WO2002044113A9 Use of(-) (3-halomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia |
| 04/24/2003 | WO2002098850A3 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors |
| 04/23/2003 | EP1063230B1 Cyclic amino compounds |
| 04/23/2003 | EP0836615B1 New thrombin inhibitors, their preparation and use |
| 04/23/2003 | CN1413217A Olefin polymerization cocatalysts derived from group-15 compounds and process using them |
| 04/22/2003 | US6552205 C10 OXO and hydrido taxane derivatives and pharmaceutical compositions containing them |
| 04/22/2003 | US6552038 Anticoagulant agents |
| 04/17/2003 | WO2003030942A1 Pharmaceutical formulation |
| 04/17/2003 | CA2458473A1 Pharmaceutical formulation |
| 04/16/2003 | EP1302458A1 Ester derivatives |
| 04/16/2003 | EP1301506A1 Cyclic amino acid derivatives |
| 04/16/2003 | EP1301482A1 Cyclic amine phenyl beta-3 adrenergic receptor agonists |
| 04/16/2003 | EP0773955B1 New thrombin inhibitors, their preparation and use |
| 04/16/2003 | CN1411440A Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof |
| 04/16/2003 | CN1105715C New pyridonecarboxylic acid derivatives or their salts and antibacterial agent comprising same as active ingredient |
| 04/15/2003 | US6548680 Process for the production of N-protected azetidine-2-carboxylic acids (azeohs) |
| 04/15/2003 | US6548293 Enzymatic process for the resolution of enantiomeric mixtures of β-lactams |
| 04/10/2003 | US20030069418 Ligands for cellular receptors, including opiate receptors; side effect reduction; base structure is a saturated nitrogen-containing ring substituted with a tertiary amide that is N-substituted with an arylalkyl group |
| 04/10/2003 | US20030069415 Enzymatic resolution of t-butyl taxane derivatives |
| 04/10/2003 | US20030069250 Anticoagulants |
| 04/10/2003 | US20030069221 Combinations of sterol absorption inhibitor(s) with cardiovascular agent(s) for the treatment of vascular conditions |
| 04/09/2003 | EP1183262A4 Intermediates for and synthesis of 3-methylene cephams |
| 04/08/2003 | US6544976 Treating disorders characterized by neuronal damage caused by disease or trauma, such as Parkinson's disease, Alzheimer's disease, stroke, multiple sclerosis, amyotrophic lateral sclerosis, diabetic neuropathy and Bell's palsy. |
| 04/03/2003 | WO2003026644A1 Methods for treating or preventing vascular inflammation using sterol absorption inhibitor(s) |
| 04/03/2003 | WO2003026643A2 Treatment of xanthoma with azetidinone derivatives as sterol absorption inhibitors |
| 04/03/2003 | US20030065200 Taxanes having T-butoxycarbonyl substituted side-chains and pharmaceutical compositions containing them |
| 04/03/2003 | US20030065187 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 04/03/2003 | CA2460344A1 Methods for treating or preventing vascular inflammation using sterol absorption inhibitor(s) |
| 04/02/2003 | EP0681574B1 C7 Taxane derivatives and pharmaceutical compositions containing them |
| 04/01/2003 | US6541242 Using a lipase; anticancer agent |
| 03/27/2003 | WO2003024924A1 Novel compounds and compositions as cathepsin inhibitors |
| 03/27/2003 | WO2002060859A3 Cyclic derivatives as modulators of chemokine receptor activity |
| 03/27/2003 | CA2460125A1 Novel compounds and compositions as cathepsin inhibitors |
| 03/26/2003 | EP1294685A1 Aryl phenycyclopropyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents |
| 03/25/2003 | CA2254273C Preparation of substituted isoserine esters using metal alkoxides and .beta.-lactams |
| 03/20/2003 | US20030055272 Antileukemia and antitumor agents |
| 03/20/2003 | US20030055033 Azetidine derivatives, their preparation and pharmaceutical compositions containing them |
| 03/19/2003 | CN1404477A 哌嗪和哌啶衍生物 Piperazine and piperidine derivatives |
| 03/18/2003 | US6534650 Benzisoxazole and 4-amidino-3-hydroxyphenyl chemical intermediates |
| 03/13/2003 | WO2002058696A3 The use of substituted azetidinone compounds for the treatment of sitosterolemia |
| 03/13/2003 | US20030050309 A gelatinase inhibitor for modulating the activity of a dopamine, serotonin, or norepinephrine receptor or transporter |
| 03/06/2003 | WO2003018551A1 New mandelic acid derivatives and their use as thrombin inhibitors |
| 03/06/2003 | US20030045730 Process for preparation of optically active n-substituted azetidine-2-carboxylic acids |